CHRISTOPHER LAMOTTE: Open Payments
NPI 1275812349 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 21 payments from 10 companies in 2025. Trend: 2023 $485 · 2024 $719 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $199 |
| BIOTRONIK INC. | 5 | $166 |
| Novo Nordisk Inc | 2 | $143 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $107 |
| ABIOMED | 1 | $97 |
| Amgen Inc. | 3 | $53 |
| Medtronic, Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: Wegovy, Acticor 7 VR-T DX, LOKELMA, LifeVest, FARXIGA, REPATHA, AZURE XT DR MRI SURESCAN, ELIQUIS.
Industry payments across TX — which companies pay providers there.
